Viora - visible through confidence is a technology company.
Viora - visible through confidence has raised $770K across 1 funding round.
Viora - visible through confidence has raised $770K in total across 1 funding round.
Viora is a medical device company specializing in advanced, non-invasive aesthetic technologies, including microdermabrasion, electro-mesotherapy, light-based systems (such as Laser and IPL), and proprietary radiofrequency (RF) platforms like the Reaction System and V-Series.[1][2][3][5] It serves dermatologists, cosmetic and plastic surgeons, general practitioners, dentists, cosmeticians, and spa owners worldwide, addressing skin rejuvenation, body sculpting, pain management (e.g., TMD-related myofascial pain), and other aesthetic treatments by providing flexible, multi-technology devices that enhance practice efficiency and patient outcomes.[1][2][5] With over 10,000 global customers across 60 countries and direct U.S. operations, Viora demonstrated strong growth until its acquisition by Sinclair Pharma in February 2022, which integrated it into Sinclair's energy-based devices portfolio.[1][2]
Viora was founded in 2005 by Josef Luzon and Danny Erez, based in New York, NY, at 213 West 35th St Suite #500.[1][2] The company emerged as a provider of innovative, non-invasive aesthetic devices, quickly establishing leadership through proprietary RF technologies and multi-platform systems like Reaction™, Infusion™ (DermaFuse™ in the U.S.), Pristine™, and V-Series.[2][5] Early traction came from its global distribution network and adoption by diverse practitioners, culminating in patents such as one for "Skin treatment using variable RF" granted in 2020.[1] By 2022, under CEO Eliran Almog, Viora was acquired by Sinclair Pharma (a London-based subsidiary of Huadong Medicine), affirming its market success and enabling expanded practice development support.[2]
Viora rides the surging demand for non-invasive aesthetic devices, fueled by rising consumer interest in minimally disruptive skin care, body sculpting, and wellness treatments amid an aging population and social media-driven beauty standards.[1][2] Its timing aligns with market growth projections, such as microdermabrasion devices reaching US$864.2 million by 2033, supported by innovations in RF and light-based tech.[1] Favorable forces include expanding medical spa sectors, dental aesthetics integration (e.g., TMD pain solutions), and post-pandemic wellness booms, positioning Viora to influence ecosystems through Sinclair's global scale and R&D synergy.[2][5] As part of Sinclair, it accelerates energy-based device adoption, bridging medtech with consumer aesthetics.
Post-acquisition, Viora will likely expand within Sinclair's portfolio, leveraging Huadong Medicine's resources for new RF iterations, AI-enhanced personalization, and deeper penetration in emerging markets.[2] Trends like at-home aesthetics hybrids and regenerative medtech will shape its path, potentially amplifying patents into broader pain management or wellness applications.[1] Its influence may evolve from standalone innovator to powerhouse enabler, empowering practitioners with "visible through confidence" outcomes—echoing its tagline by making advanced aesthetics accessible and effective worldwide.[2]
Viora - visible through confidence has raised $770K in total across 1 funding round.
Viora - visible through confidence's investors include Amadeus Capital Partners, Bernhard Niesner.
Viora - visible through confidence has raised $770K across 1 funding round. Most recently, it raised $770K Viora - Seed in July 2023.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jul 1, 2023 | $770K Viora - Seed | Amadeus Capital Partners, Bernhard Niesner |